Home › Trial NCT01949337
Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer
- Trial IDNCT01949337
- StatusUnknown
- PhasePhase 3
- Study typeInterventional
- SponsorAlliance for Clinical Trials in Oncology
- Enrollment1311
- Start date2014-01-22
- ConditionsAdenocarcinoma of the Prostate · Hormone-resistant Prostate Cancer · Recurrent Prostate Cancer · Stage IV Prostate Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.